REPORT ID 3625

Global Anti-Inflammatory Drugs (NSAIDs) Sales Market Report 2017

Publish Date
14-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the global Anti-Inflammatory Drugs (NSAIDs) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Anti-Inflammatory Drugs (NSAIDs) for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Anti-Inflammatory Drugs (NSAIDs) market competition by top manufacturers/players, with Anti-Inflammatory Drugs (NSAIDs) sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AbbVie
    Amgen
    AstraZeneca
    Eli Lily
    GlaxoSmithKline
    Roche
    Johnson & Johnson
    Merck
    Novartis
    Pfizer
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Anti-inflammatory Biologics
    Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Corticosteroids
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hosptical
    Pharmacy
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Anti-Inflammatory Drugs (NSAIDs) Sales Market Report 2017
1 Anti-Inflammatory Drugs (NSAIDs) Market Overview
    1.1 Product Overview and Scope of Anti-Inflammatory Drugs (NSAIDs)
    1.2 Classification of Anti-Inflammatory Drugs (NSAIDs) by Product Category
        1.2.1 Global Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-inflammatory Biologics
        1.2.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
        1.2.5 Corticosteroids
        1.2.6 Others
    1.3 Global Anti-Inflammatory Drugs (NSAIDs) Market by Application/End Users
        1.3.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hosptical
        1.3.3 Pharmacy
        1.3.4 Other
    1.4 Global Anti-Inflammatory Drugs (NSAIDs) Market by Region
        1.4.1 Global Anti-Inflammatory Drugs (NSAIDs) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
        1.4.3 China Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
        1.4.4 Europe Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
        1.4.5 Japan Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
        1.4.7 India Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Anti-Inflammatory Drugs (NSAIDs) (2012-2022)
        1.5.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2022)
        1.5.2 Global Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2022)

2 Global Anti-Inflammatory Drugs (NSAIDs) Competition by Players/Suppliers, Type and Application
     2.1 Global Anti-Inflammatory Drugs (NSAIDs) Market Competition by Players/Suppliers
        2.1.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Anti-Inflammatory Drugs (NSAIDs) (Volume and Value) by Type
        2.2.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type (2012-2017)
        2.2.2 Global Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2012-2017)
    2.3 Global Anti-Inflammatory Drugs (NSAIDs) (Volume and Value) by Region
        2.3.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Region (2012-2017)
        2.3.2 Global Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Region (2012-2017)
    2.4 Global Anti-Inflammatory Drugs (NSAIDs) (Volume) by Application

3 United States Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price)
    3.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
        3.1.1 United States Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
        3.1.2 United States Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
        3.1.3 United States Anti-Inflammatory Drugs (NSAIDs) Sales Price Trend (2012-2017)
    3.2 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Players
    3.3 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Type
    3.4 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Application

4 China Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price)
    4.1 China Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
        4.1.1 China Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
        4.1.2 China Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
        4.1.3 China Anti-Inflammatory Drugs (NSAIDs) Sales Price Trend (2012-2017)
    4.2 China Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Players
    4.3 China Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Type
    4.4 China Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Application

5 Europe Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price)
    5.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
        5.1.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
        5.1.2 Europe Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Price Trend (2012-2017)
    5.2 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Players
    5.3 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Type
    5.4 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Application

6 Japan Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price)
    6.1 Japan Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
        6.1.1 Japan Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
        6.1.2 Japan Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Anti-Inflammatory Drugs (NSAIDs) Sales Price Trend (2012-2017)
    6.2 Japan Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Players
    6.3 Japan Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Type
    6.4 Japan Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Application

7 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price)
    7.1 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
        7.1.1 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Sales Price Trend (2012-2017)
    7.2 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Players
    7.3 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Type
    7.4 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Application

8 India Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price)
    8.1 India Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
        8.1.1 India Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
        8.1.2 India Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
        8.1.3 India Anti-Inflammatory Drugs (NSAIDs) Sales Price Trend (2012-2017)
    8.2 India Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Players
    8.3 India Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Type
    8.4 India Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share by Application

9 Global Anti-Inflammatory Drugs (NSAIDs) Players/Suppliers Profiles and Sales Data
    9.1 AbbVie
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Amgen
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Amgen Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 AstraZeneca
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Eli Lily
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 GlaxoSmithKline
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Roche
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Roche Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Johnson & Johnson
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Merck
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Merck Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Novartis
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Novartis Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Pfizer
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Anti-Inflammatory Drugs (NSAIDs) Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview

10 Anti-Inflammatory Drugs (NSAIDs) Maufacturing Cost Analysis
    10.1 Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Anti-Inflammatory Drugs (NSAIDs)
    10.3 Manufacturing Process Analysis of Anti-Inflammatory Drugs (NSAIDs)

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Anti-Inflammatory Drugs (NSAIDs) Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Anti-Inflammatory Drugs (NSAIDs) Market Forecast (2017-2022)
    14.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Anti-Inflammatory Drugs (NSAIDs) Price and Trend Forecast (2017-2022)
    14.2 Global Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Type (2017-2022)
       14.3.2 Global Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Type (2017-2022)
       14.3.3 Global Anti-Inflammatory Drugs (NSAIDs) Price Forecast by Type (2017-2022)
    14.4 Global Anti-Inflammatory Drugs (NSAIDs) Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research